• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病患者的新型隐球菌抗体水平。

Cryptococcus neoformans antibody levels in patients with AIDS.

作者信息

Dromer F, Aucouturier P, Clauvel J P, Saimot G, Yeni P

机构信息

Laboratoire des Infections Expérimentales, Faculté Xavier Bichat, Paris, France.

出版信息

Scand J Infect Dis. 1988;20(3):283-5. doi: 10.3109/00365548809032452.

DOI:10.3109/00365548809032452
PMID:3043650
Abstract

Anti-Cryptococcus neoformans capsular polysaccharide (CPS) antibodies were measured by ELISA in patients with AIDS related complex or AIDS without a known history of cryptococcosis and in heterosexual healthy controls. Total and IgG anti-CPS antibody activity was rarely detected in patients, with mean levels lower than in controls, whereas IgM antibody activity was similar in the 3 groups. Since both humoral and cellular immunity appear to be of great importance during cryptococcosis, the inability of AIDS patients to synthetize specific IgG antibodies could impair an alternative host defence mechanism to cellular immunity.

摘要

采用酶联免疫吸附测定法(ELISA)检测了艾滋病相关综合征患者或无隐球菌病已知病史的艾滋病患者以及异性健康对照者体内的抗新型隐球菌荚膜多糖(CPS)抗体。在患者中很少检测到总抗CPS抗体活性和IgG抗CPS抗体活性,其平均水平低于对照组,而IgM抗体活性在三组中相似。由于在隐球菌病期间体液免疫和细胞免疫似乎都非常重要,艾滋病患者无法合成特异性IgG抗体可能会损害细胞免疫的一种替代宿主防御机制。

相似文献

1
Cryptococcus neoformans antibody levels in patients with AIDS.艾滋病患者的新型隐球菌抗体水平。
Scand J Infect Dis. 1988;20(3):283-5. doi: 10.3109/00365548809032452.
2
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.酶免疫法检测新型隐球菌半乳甘露聚糖的IgM
Diagn Immunol. 1984;2(2):109-15.
3
Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.印度隐球菌病患者对新型隐球菌的抗体反应。
Med Mycol. 2008 Aug;46(5):457-63. doi: 10.1080/13693780801961345. Epub 2008 Mar 10.
4
Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.实体器官移植患者对新型隐球菌荚膜多糖葡糖醛酸木糖甘露聚糖的抗体反应。
Clin Vaccine Immunol. 2006 Jul;13(7):740-6. doi: 10.1128/CVI.00139-06.
5
Characterization of immunoglobulin classes of human antibodies to cryptococcus neoformans.人抗新型隐球菌抗体免疫球蛋白类别的鉴定
Mycopathologia. 1977 Jul 29;61(1):55-60. doi: 10.1007/BF00440759.
6
Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody.对新型隐球菌可溶性多糖的免疫反应。I. 抗原和抗体的血清学检测
Infect Immun. 1972 Jan;5(1):35-41. doi: 10.1128/iai.5.1.35-41.1972.
7
Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.一种与新型隐球菌荚膜多糖反应的小鼠单克隆抗体的制备、特性鉴定及抗体特异性
Infect Immun. 1987 Mar;55(3):742-8. doi: 10.1128/iai.55.3.742-748.1987.
8
The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.经典补体途径和替代补体途径在宿主抵御新型隐球菌感染中的作用。
J Immunol. 1974 Jun;112(6):2260-70.
9
Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.与隐球菌荚膜多糖葡糖醛酸木糖甘露聚糖反应的抗体存在于感染和未感染人类免疫缺陷病毒的儿童血清中。
J Infect Dis. 1999 Sep;180(3):915-9. doi: 10.1086/314953.
10
Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.新型隐球菌可溶性多糖诱导体液抗体反应
Mycopathol Mycol Appl. 1974 Oct 15;54(1):21-30. doi: 10.1007/BF02055969.

引用本文的文献

1
Pathogenicity and virulence of Cryptococcus neoformans from an environmental perspective.从环境角度看新型隐球菌的致病性和毒力
Virulence. 2025 Dec;16(1):2547090. doi: 10.1080/21505594.2025.2547090. Epub 2025 Aug 14.
2
infections: aspartyl protease potential to improve outcome in susceptible hosts.感染:天冬氨酸蛋白酶有可能改善易感宿主的预后。
mBio. 2024 Nov 13;15(11):e0273324. doi: 10.1128/mbio.02733-24. Epub 2024 Oct 23.
3
Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.
鉴定与新型隐球菌性脑膜炎患者血清 IgG 反应的疾病相关隐球菌蛋白。
Front Immunol. 2021 Jul 23;12:709695. doi: 10.3389/fimmu.2021.709695. eCollection 2021.
4
Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model.葡聚糖醛酸木聚糖和甾基葡糖苷是动物疫苗接种模型中宿主保护所必需的。
mBio. 2019 Apr 2;10(2):e02909-18. doi: 10.1128/mBio.02909-18.
5
Host immunity to Cryptococcus neoformans.宿主对新型隐球菌的免疫
Future Microbiol. 2015;10(4):565-81. doi: 10.2217/fmb.14.132.
6
Distinct and redundant roles of exonucleases in Cryptococcus neoformans: implications for virulence and mating.核酸外切酶在新型隐球菌中的不同及冗余作用:对毒力和交配的影响
Fungal Genet Biol. 2014 Dec;73:20-8. doi: 10.1016/j.fgb.2014.09.007. Epub 2014 Sep 28.
7
The copper regulon of the human fungal pathogen Cryptococcus neoformans H99.人类真菌病原体新型隐球菌 H99 的铜调控基因簇。
Mol Microbiol. 2011 Sep;81(6):1560-76. doi: 10.1111/j.1365-2958.2011.07794.x. Epub 2011 Aug 23.
8
A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.荚膜独立吞噬抑制机制在新型隐球菌感染哺乳动物中的主要作用。
Cell Host Microbe. 2011 Mar 17;9(3):243-251. doi: 10.1016/j.chom.2011.02.003.
9
Cryptococcal cell morphology affects host cell interactions and pathogenicity.隐球菌细胞形态影响宿主细胞相互作用和致病性。
PLoS Pathog. 2010 Jun 17;6(6):e1000953. doi: 10.1371/journal.ppat.1000953.
10
Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.印度隐球菌病患者对新型隐球菌的抗体反应。
Med Mycol. 2008 Aug;46(5):457-63. doi: 10.1080/13693780801961345. Epub 2008 Mar 10.